VAF
REGN icon

Values Added Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Values Added Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-282
Closed -$218K – 151
2026
Q1 		$218K Buy
282
+3
+1% +$2.3K 0.09% 122
2025
Q4 		$215K Buy
+279
New +$189K 0.09% 125

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Values Added Financial's REGN Position: Q2 2026 in Review

Values Added Financial sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 282 shares — an estimated $218K sold.

Values Added Financial first reported a position in REGN in Q4 2025 and held it in 2 quarters. The position peaked at $218K in Q1 2026. 454 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Values Added Financial reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Values Added Financial sold 282 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $218K.
  • Values Added Financial first reported a position in Regeneron Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Values Added Financial's Regeneron Pharmaceuticals position peaked at $218K in Q1 2026.
  • 454 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Values Added Financial's 13F filing for Q2 2026, filed 27 Jul 2026.